{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:26:12Z","timestamp":1791285972044,"version":"4.1.0"},"reference-count":59,"publisher":"American Society for Microbiology","issue":"22","license":[{"start":{"date-parts":[[2002,11,15]],"date-time":"2002-11-15T00:00:00Z","timestamp":1037318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Virol"],"published-print":{"date-parts":[[2002,11,15]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            Humans chronically infected with hepatitis B virus (HBV) are at further risk of liver cancer upon exposure to dietary aflatoxin B1 (AFB1), a carcinogenic product of the mold\n            <jats:italic>Aspergillus flavus.<\/jats:italic>\n            For the present study, we utilized double-transgenic mice (ATX mice) that express the HBV X protein (HBx) and possess a bacteriophage lambda transgene to evaluate the in vivo effect of HBx expression on AFB1-induced DNA mutations. The expression of HBx correlated with a 24% increase in mutation frequency overall and an approximately twofold increase in the incidence of G\/C-to-T\/A transversion mutations following AFB1 exposure. These results are consistent with a model in which expression of HBx during chronic HBV infection may contribute to the development of hepatocellular carcinoma following exposure to environmental carcinogens.\n          <\/jats:p>","DOI":"10.1128\/jvi.76.22.11770-11774.2002","type":"journal-article","created":{"date-parts":[[2002,10,19]],"date-time":"2002-10-19T05:23:55Z","timestamp":1035005035000},"page":"11770-11774","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":53,"title":["Altered DNA Mutation Spectrum in Aflatoxin B1-Treated Transgenic Mice That Express the Hepatitis B Virus X Protein"],"prefix":"10.1128","volume":"76","author":[{"given":"Charles R.","family":"Madden","sequence":"first","affiliation":[{"name":"Department of Molecular Virology and Microbiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milton J.","family":"Finegold","sequence":"additional","affiliation":[{"name":"Department of Pathology, Baylor College of Medicine, Houston, Texas 77030"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betty L.","family":"Slagle","sequence":"additional","affiliation":[{"name":"Department of Molecular Virology and Microbiology"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1093\/mutage\/11.1.69"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19880515)61:10<1942::AID-CNCR2820611003>3.0.CO;2-J"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.72.1.266-272.1998"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.24.11215"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/350429a0"},{"key":"e_1_3_2_7_2","first-page":"4436","volume":"54","year":"1994","unstructured":"Cariello, N. F., L. Cui, and T. R. Skopek. 1994. In vitro mutational spectrum of aflatoxin B1 in the human hypoxanthine guanine phosphoribosyltransferase gene. Cancer Res. 54 : 4436-4441.","journal-title":"Cancer Res."},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.1997.tb00513.x"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.67.3.1218-1226.1993"},{"key":"e_1_3_2_10_2","first-page":"595","volume":"103","year":"1998","unstructured":"Chomarat, P., J. M. Rice, B. L. Slagle, and C. P. Wild. 1998. Hepatitis B virus-induced liver injury and altered expression of carcinogen metabolising enzymes: the role of the HBx protein. Toxicol. Lett. 103 : 595-601.","journal-title":"Toxicol. Lett."},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.70.8.5246-5254.1996"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M006026200"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/17.11.2347"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.3109\/03602538209011088"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510270211"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510270411"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1539-6924.1990.tb00538.x"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/20.3.479"},{"key":"e_1_3_2_19_2","unstructured":"Groopman J. D. G. Sabbioni and C. P. Wild. 1991. Molecular dosimetry of human aflatoxin exposures p. 303-324. In J. D. Groopman and P. L. Skipper (ed.) Molecular dosimetry and human cancer: analytical epidemiological and social considerations. CRC Press Boca Raton Fla."},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1038\/350427a0"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.17.9073"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19990315)80:6<875::AID-IJC13>3.0.CO;2-Z"},{"key":"e_1_3_2_23_2","first-page":"61","volume":"20","year":"2001","unstructured":"Johnson, W. J. 2001. Final report on the safety assessment of trilaurin, triarachidin, tribehenin, tricaprin, tricaprylin, trierucin, triheptanoin, triheptylundecanoin, triisononanoin, triisopalmitin, triisostearin, trilinolein, trimyristin, trioctanoin, triolein, tripalmitin, tripalmitolein, triricinolein, tristearin, triundecanoin, glyceryl triacetyl hydroxystearate, glyceryl triacetyl ricinoleate, and gl. Int. J. Toxicol. 20(Suppl. 4): 61-94.","journal-title":"Int. J. Toxicol."},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.1.381"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/mc.2940110204"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/0735-0651(90)90003-X"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI117343"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M108025200"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.69.2.1107-1114.1995"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.64.12.5939-5947.1990"},{"key":"e_1_3_2_31_2","first-page":"5668","volume":"52","year":"1992","unstructured":"Levy, D. D., J. D. Groopman, S. E. Lim, M. M. Seidman, and K. H. Kraemer. 1992. Sequence specificity of aflatoxin B1-induced mutations in a plasmid replicated in xeroderma pigmentosum and DNA repair proficient human cells. Cancer Res. 52 : 5668-5673.","journal-title":"Cancer Res."},{"key":"e_1_3_2_32_2","first-page":"3471","volume":"57","year":"1997","unstructured":"Lunn, R. M., Y. J. Zhang, L. Y. Wang, C. J. Chen, P. H. Lee, C. S. Lee, W. Y. Tsai, and R. M. Santella. 1997. p53 mutations, chronic hepatitis B virus infection, and aflatoxin exposure in hepatocellular carcinoma in Taiwan. Cancer Res. 57 : 3471-3477.","journal-title":"Cancer Res."},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.74.11.5266-5272.2000"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.75.8.3851-3858.2001"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)47588-6"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.87.3.1104"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1002\/1098-2280(2000)35:4<319::AID-EM6>3.0.CO;2-H"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1021\/bi00283a008"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.80.1.6"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-82-1-171"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0753-3322(99)80003-1"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.50.33327"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/17.12.2689"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1093\/mutage\/13.2.173"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1093\/genetics\/120.4.863"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1038\/272410a0"},{"key":"e_1_3_2_47_2","first-page":"1278","volume":"51","year":"1991","unstructured":"Sell, S., J. M. Hunt, H. A. Dunsford, and F. V. Chisari. 1991. Synergy between hepatitis B virus expression and chemical hepatocarcinogens in transgenic mice. Cancer Res. 51 : 1278-1285.","journal-title":"Cancer Res."},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1203770"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.71.8.6194-6199.1997"},{"key":"e_1_3_2_50_2","unstructured":"Slagle B. L. S. A. Becker and J. S. Butel. 1994. Hepatitis viruses and liver cancer p. 149-171. In A. Minson J. Neil and M. McCrae (ed.) Viruses and cancer vol. 51. University of Cambridge Cambridge England."},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-2744(199604)15:4<261::AID-MC3>3.0.CO;2-J"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-2280(1999)33:4<293::AID-EM6>3.0.CO;2-E"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.16.8744"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510300204"},{"key":"e_1_3_2_55_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1205110"},{"key":"e_1_3_2_56_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1202432"},{"key":"e_1_3_2_57_2","first-page":"S2114","volume":"52","year":"1992","unstructured":"Wogan, G. N. 1992. Aflatoxins as risk factors for hepatocellular carcinoma in humans. Cancer Res. 52 : S2114-S2118.","journal-title":"Cancer Res."},{"key":"e_1_3_2_58_2","first-page":"2506","volume":"49","year":"1989","unstructured":"Yeh, F.-S., M. C. Yu, C.-C. Mo, S. Luo, M. J. Tong, and B. E. Henderson. 1989. Hepatitis B virus, aflatoxins, and hepatocellular carcinoma in southern Guangxi, China. Cancer Res. 49 : 2506-2509.","journal-title":"Cancer Res."},{"key":"e_1_3_2_59_2","doi-asserted-by":"publisher","DOI":"10.1155\/2000\/371801"},{"key":"e_1_3_2_60_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.68.3.2026-2030.1994"}],"container-title":["Journal of Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JVI.76.22.11770-11774.2002","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JVI.76.22.11770-11774.2002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T07:27:53Z","timestamp":1646465273000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/JVI.76.22.11770-11774.2002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,11,15]]},"references-count":59,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2002,11,15]]}},"alternative-id":["10.1128\/JVI.76.22.11770-11774.2002"],"URL":"https:\/\/doi.org\/10.1128\/jvi.76.22.11770-11774.2002","relation":{},"ISSN":["0022-538X","1098-5514"],"issn-type":[{"value":"0022-538X","type":"print"},{"value":"1098-5514","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,11,15]]},"assertion":[{"value":"2002-04-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2002-08-14","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2002-11-15","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}